Impacts of Fermented Plant-based Products High in Protein on Gut Microbiota and Health - Trial NCT06393114
Access comprehensive clinical trial information for NCT06393114 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Eastern Finland and is currently Recruitment Completed. The study focuses on Metabolic Syndrome. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Eastern Finland
Timeline & Enrollment
N/A
Jan 22, 2024
Dec 01, 2024
Primary Outcome
Inflammatory marker 1,Inflammatory marker 2,Inflammatory marker 3
Summary
This study aims to investigate the effects of consuming fermented oat-based products on gut
 and overall human health. It is a randomized, controlled, cross-over trial with a dietary
 intervention.
 
 A total of 100 participants will be enrolled in this study and they will eat both fermented
 and unfermented oat-based products for three weeks. Participants will eat their habitual diet
 between the dietary intervention periods (wash-out).
 
 During the study, participants' perceived health, inflammatory markers, glucose and lipid
 metabolism, tryptophan metabolites, gastrointestinal symptoms, and gut microbiota will be
 assessed.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06393114
Non-Device Trial